1-3 of 3
Sajitha Sachchithanantham, BSc,MBBS,MRCP,FRCPath,
Close
Sort by
Journal Articles

A European Collaborative Study of 230 Patients to Assess the Role of Cyclophosphamide, Bortezomib and Dexamethasone in Upfront Treatment of Patients with Systemic AL Amyloidosis

Giovanni Palladini, MD PhD, Sajitha Sachchithanantham, BSc,MBBS,MRCP,FRCPath,, Paolo Milani, MD, Julian D Gillmore, Andrea Foli, MD, Philip N Hawkins, Giampaolo Merlini, MD, Ashutosh D Wechalekar
Journal: Blood
Blood (2014) 124 (21): 305.
https://doi.org/10.1182/blood.V124.21.305.305
Published: 2014
Journal Articles

Exome Sequencing to Define a Genetic Signature of Plasma Cells in Systemic AL Amyloidosis

Eileen M Boyle, MD, Brian A Walker, PhD, Dorota Rowczienio, MSc, Christopher P Wardell, PhD, Alexander Murison, PhD, Aneta Mikulasova, M.Sc., Sajitha Sachchithanantham, BSc,MBBS,MRCP,FRCPath,, Anna Baginska, Shameem Mahmood, MRCP. FRCPath, Julian D Gillmore, Helen J Lachmann, MD FRCP, Philip N Hawkins, MD FRCP, FMedSci, Xavier Leleu, MD PhD, Faith E Davies, MD, Gareth J. Morgan, MD PhD, Ashutosh Wechalekar, MDFRCPath
Journal: Blood
Blood (2014) 124 (21): 726.
https://doi.org/10.1182/blood.V124.21.726.726
Published: 2014
Journal Articles

The Prognostic Significance of Phenotypically ‘Normal’ Plasma Cells in Chemotherapy Treated AL Patients with Underlying MGUS and Multiple Myeloma

Sajitha Sachchithanantham, BSc,MBBS,MRCP,FRCPath,, Ruth M de Tute, Anna Baginska, Christopher Parrish, MD, Shameem Mahmood, MRCP. FRCPath, Andy Rawstron, PhD, Julian D Gillmore, MD FRCP, Helen J Lachmann, MD FRCP, Philip N Hawkins, Roger G Owen, MD, Ashutosh Wechalekar, Dr
Journal: Blood
Blood (2014) 124 (21): 2073.
https://doi.org/10.1182/blood.V124.21.2073.2073
Published: 2014